Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,348 | 620 | 83.1% |
| Travel and Lodging | $4,181 | 17 | 16.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $158.18 | 1 | 0.6% |
| Education | $1.14 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nevro Corp. | $5,416 | 87 | $0 (2024) |
| Medtronic, Inc. | $4,365 | 39 | $0 (2024) |
| Abbott Laboratories | $3,116 | 55 | $0 (2024) |
| Vertiflex, Inc. | $1,628 | 25 | $0 (2019) |
| Medtronic USA, Inc. | $1,603 | 34 | $0 (2020) |
| Relievant Medsystems, Inc. | $1,478 | 13 | $0 (2023) |
| Boston Scientific Corporation | $1,339 | 47 | $0 (2024) |
| Vertos Medical, Inc. | $762.96 | 28 | $0 (2024) |
| SPR Therapeutics, Inc | $695.99 | 10 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $634.23 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,009 | 34 | Boston Scientific Corporation ($342.97) |
| 2023 | $3,012 | 52 | Medtronic, Inc. ($1,993) |
| 2022 | $3,664 | 52 | Medtronic, Inc. ($2,052) |
| 2021 | $4,210 | 74 | Nevro Corp. ($1,681) |
| 2020 | $3,136 | 86 | Nevro Corp. ($1,606) |
| 2019 | $4,590 | 94 | Vertiflex, Inc. ($1,339) |
| 2018 | $3,247 | 108 | Abbott Laboratories ($1,158) |
| 2017 | $2,820 | 141 | Abbott Laboratories ($448.51) |
All Payment Transactions
641 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $6.26 | General |
| Category: Pain management | ||||||
| 12/05/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.81 | General |
| Category: Opioid Analgesic | ||||||
| 12/02/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/26/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: INSTRUMENTS | ||||||
| 11/22/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $128.63 | General |
| Category: Pain management | ||||||
| 11/21/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: INSTRUMENTS | ||||||
| 11/08/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Neuromodulation | ||||||
| 11/07/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.05 | General |
| Category: Opioid Analgesic | ||||||
| 10/24/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: INSTRUMENTS | ||||||
| 10/03/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $19.19 | General |
| Category: Opioid Analgesic | ||||||
| 09/25/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: INSTRUMENTS | ||||||
| 09/20/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.19 | General |
| 09/19/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Orthopedic | ||||||
| 08/15/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.34 | General |
| Category: Opioid Analgesic | ||||||
| 08/08/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $16.91 | General |
| 07/30/2024 | Spinal Simplicity, LLC | HA MINUTEMAN G3-R (Device) | Food and Beverage | In-kind items and services | $30.26 | General |
| Category: SPINAL HARDWARE | ||||||
| 07/18/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.02 | General |
| Category: Opioid Analgesic | ||||||
| 07/09/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.77 | General |
| Category: Opioid Analgesic | ||||||
| 07/08/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Orthopedic | ||||||
| 06/06/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $19.94 | General |
| Category: Opioid Analgesic | ||||||
| 05/15/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Gastroenterology | ||||||
| 05/03/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: General - Pain Management_NMD | ||||||
| 04/04/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $135.03 | General |
| Category: General - Pain Management_NMD | ||||||
| 04/03/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: General - Pain Management_NMD | ||||||
| 04/02/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $33.83 | General |
| Category: Spinal Cord Stimulator | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,346 | 3,701 | $1.2M | $352,524 |
| 2022 | 20 | 1,287 | 3,882 | $1.5M | $363,847 |
| 2021 | 21 | 1,401 | 4,141 | $2.4M | $406,990 |
| 2020 | 19 | 1,414 | 3,842 | $2.1M | $346,235 |
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 428 | 2,020 | $404,000 | $183,120 | 45.3% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 254 | 485 | $289,060 | $94,111 | 32.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 203 | 278 | $51,708 | $16,820 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 122 | 122 | $45,750 | $14,497 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 93 | 139 | $23,630 | $9,281 | 39.3% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 45 | 81 | $81,200 | $8,459 | 10.4% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 22 | 29 | $13,630 | $4,450 | 32.7% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 15 | 17 | $48,960 | $3,960 | 8.1% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2023 | 12 | 50 | $32,500 | $3,420 | 10.5% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 24 | 33 | $37,950 | $2,659 | 7.0% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 14 | 52 | $39,000 | $2,439 | 6.3% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 27 | 49 | $30,625 | $1,963 | 6.4% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 11 | 17 | $23,120 | $1,881 | 8.1% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 12 | 17 | $21,000 | $1,584 | 7.5% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 13 | 18 | $19,800 | $1,563 | 7.9% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 15 | 17 | $24,480 | $1,226 | 5.0% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 11 | 17 | $17,000 | $1,066 | 6.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 25 | 260 | $1,300 | $23.53 | 1.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 330 | 1,965 | $393,000 | $184,448 | 46.9% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 252 | 464 | $461,872 | $90,551 | 19.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 266 | 492 | $126,818 | $29,994 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 103 | 103 | $38,625 | $12,480 | 32.3% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 32 | 68 | $68,150 | $7,173 | 10.5% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 18 | 19 | $51,840 | $4,456 | 8.6% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2022 | 13 | 63 | $40,950 | $4,373 | 10.7% |
About Dr. Jason Peter, D.O
Dr. Jason Peter, D.O is a Pain Medicine healthcare provider based in Troy, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1851581789.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Peter, D.O has received a total of $25,688 in payments from pharmaceutical and medical device companies, with $1,009 received in 2024. These payments were reported across 641 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($21,348).
As a Medicare-enrolled provider, Peter has provided services to 5,448 Medicare beneficiaries, totaling 15,566 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Other Specialties Physical Medicine & Rehabilitation
- Location Troy, MI
- Active Since 07/26/2007
- Last Updated 01/27/2026
- Taxonomy Code 208VP0000X
- Entity Type Individual
- NPI Number 1851581789
Products in Payments
- Senza Spinal Cord Stimulation System (Device) $2,820
- Omnia (Device) $2,336
- SYNCHROMEDII (Device) $1,970
- INTELLIS ADAPTIVESTIM (Device) $1,969
- Superion ISS (Device) $1,628
- Intracept (Device) $1,483
- INTELLIS (Device) $1,163
- Proclaim Family of SCS IPGs (Device) $1,150
- Axium INS DRG IPG (Device) $827.51
- mild Device Kit (Device) $762.96
- SPRINT PNS System (Device) $695.99
- LYRICA (Drug) $574.08
- Proclaim IPG (Device) $395.77
- XTAMPZA (Drug) $356.39
- SCS IPGs (Device) $345.68
- Morphabond ER (Drug) $294.76
- Senza (Device) $260.36
- MAGNIFUSE (Device) $238.81
- GENERAL PAIN MANAGEMENT (Device) $227.98
- HA MINUTEMAN G3-R (Device) $210.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.